Advances Second Late Stage Program for ADAM Microneedle Technology FREMONT, Calif., Oct. 24, 2019 (GLOBE NEWSWIRE) — Zosano Pharma Corporation (ZSAN), a clinical-stage biopharmaceutical company, today announced that the company has begun enrolling cluster...
– Generalized anxiety disorder impacts approximately 7 million U.S. adults annually and many do not fully respond to current therapies – Troriluzole is a new chemical entity that modulates glutamate in an effort to reduce the severity of anxiety, worry and...
Replimune’s second product candidate to enter the clinic is an Immulytic™ that expresses an anti-CTLA-4 antibody-like protein WOBURN, Mass., Oct. 24, 2019 (GLOBE NEWSWIRE) — Replimune Group Inc. (REPL), a biotechnology company developing oncolytic immuno-gene...
MCY-M11 is being evaluated in relapsed/refractory ovarian cancer and peritoneal mesothelioma CARMA platform offers faster manufacturing speeds, broader therapeutic applications, combination opportunities and repeat dosing potential GAITHERSBURG, Md., Oct. 24,...
WALTHAM, Mass., Oct. 25, 2019 (GLOBE NEWSWIRE) — AMAG Pharmaceuticals, Inc. (AMAG) today announced that the results of PROLONG (Progestin’s Role in Optimizing Neonatal Gestation) were published online in the American Journal of Perinatology. PROLONG was a...
Founder Mike Wenger to Join Staff as Vice President of Patient Engagement JERSEY CITY, NJ, US – Oct 24, 2019 – TrialScope, the global leader in transparency and disclosure compliance solutions, has acquired Clinical Trial Connect, a platform used by...
Email
Text